{"id":660,"date":"2022-10-20T16:41:00","date_gmt":"2022-10-20T21:41:00","guid":{"rendered":"https:\/\/www.curejm.org\/?p=660"},"modified":"2024-09-19T14:40:45","modified_gmt":"2024-09-19T18:40:45","slug":"actualizacion-sobre-un-nuevo-farmaco-prometedor-para-tratar-la-jm-vamorolona","status":"publish","type":"post","link":"https:\/\/www.curejm.org\/es\/update-on-a-promising-new-drug-to-treat-jm-vamorolone\/","title":{"rendered":"Actualizaci\u00f3n sobre un nuevo f\u00e1rmaco prometedor para tratar la JM: la vamorolona"},"content":{"rendered":"<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe title=\"Actualizaci\u00f3n sobre un nuevo f\u00e1rmaco prometedor para tratar la JM: la vamorolona\" width=\"800\" height=\"450\" src=\"https:\/\/www.youtube.com\/embed\/cAnY4rVUK1I?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Cure JM est\u00e1 haciendo extraordinarios progresos en la investigaci\u00f3n de la miositis juvenil (JM), incluida una asociaci\u00f3n con ReveraGen Biotech para avanzar en el f\u00e1rmaco vamorolona hacia un ensayo cl\u00ednico en JM.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Vamorolone es un sustituto de esteroides con todos los beneficios del tratamiento con esteroides sin efectos secundarios devastadores. Vamorolone se encuentra actualmente en un ensayo cl\u00ednico en ni\u00f1os con Distrofia Muscular de Duchenne.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Los resultados obtenidos hasta ahora indican una mayor seguridad en comparaci\u00f3n con la prednisona. Cure JM est\u00e1 trabajando con el patrocinador de la vamorolona, ReveraGen, en el dise\u00f1o de un ensayo cl\u00ednico para comprobar la seguridad del f\u00e1rmaco en ni\u00f1os con JM. El vicepresidente de investigaci\u00f3n de ReveraGen, el doctor Eric Hoffmann, nos pone al d\u00eda sobre la vamorolona y el estado del ensayo cl\u00ednico en la JM.<\/p>","protected":false},"excerpt":{"rendered":"<p>Cure JM est\u00e1 haciendo extraordinarios progresos en la investigaci\u00f3n de la miositis juvenil, incluida una asociaci\u00f3n con ReveraGen Biotech para avanzar en el f\u00e1rmaco vamorolona hacia un ensayo cl\u00ednico en la JM.<\/p>","protected":false},"author":5,"featured_media":712,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_titles_title":"","_seopress_titles_desc":"Cure JM is making extraordinary progress in juvenile myositis research, including a partnership with ReveraGen Biotech to advance the drug vamorolone toward a clinical trial in JM.","_seopress_robots_index":"","_seopress_robots_follow":"","_seopress_robots_imageindex":"","_seopress_robots_snippet":"","_seopress_robots_primary_cat":"none","_seopress_robots_breadcrumbs":"","_seopress_robots_freeze_modified_date":"","_seopress_robots_custom_modified_date":"","_seopress_robots_canonical":"","_seopress_social_fb_title":"","_seopress_social_fb_desc":"","_seopress_social_fb_img":"https:\/\/www.curejm.org\/wp-content\/uploads\/drug-treatment-vamorolone.jpeg","_seopress_social_fb_img_attachment_id":712,"_seopress_social_fb_img_width":1280,"_seopress_social_fb_img_height":720,"_seopress_social_twitter_title":"","_seopress_social_twitter_desc":"","_seopress_social_twitter_img":"","_seopress_social_twitter_img_attachment_id":0,"_seopress_social_twitter_img_width":0,"_seopress_social_twitter_img_height":0,"_seopress_redirections_value":"","_seopress_redirections_enabled":"","_seopress_redirections_enabled_regex":"","_seopress_redirections_logged_status":"both","_seopress_redirections_param":"","_seopress_redirections_type":301,"_seopress_analysis_target_kw":"","_seopress_news_disabled":"","_seopress_video_disabled":"","_seopress_video":[],"_seopress_pro_schemas_manual":[{"_seopress_pro_rich_snippets_type":"none"}],"_seopress_pro_rich_snippets_disable_all":"","_seopress_pro_rich_snippets_disable":[],"_seopress_pro_schemas":[],"footnotes":""},"categories":[1],"post_tag":[71],"class_list":["post-660","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized","tag-page-town-halls"],"_links":{"self":[{"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/posts\/660","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/comments?post=660"}],"version-history":[{"count":0,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/posts\/660\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/media\/712"}],"wp:attachment":[{"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/media?parent=660"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/categories?post=660"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curejm.org\/es\/wp-json\/wp\/v2\/post_tag?post=660"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}